ASCO 2025 — Let’s Talk About What’s Next in Oncology

Read article

Bispecific Antibody Treatments, AML & Immunotherapy Treatments

With the ASH 2018 annual meeting right around…
Read Article

Case Study: Oncology Expert Review of Clinical Data

A top 5 pharmaceutical company had a severe…
Read Article

Case Study: Accelerated Completion of a Cancer Vaccine Trial

A US client contracted Medelis to conduct a…
Read Article

ASCO 2018

The ASCO 2018 Annual Meeting takes place June…
Read Article

Guidelines for the Evaluation of Immune Therapy Activity

In a previous article, we discussed therapies that…
Read Article

Case Study: Rapid Phase I Study Start-Up and Conduct

A European client contracted with Medelis to conduct…
Read Article

Therapies That Might Affect the Cancer-Immunity Cycle

In the last five years we’ve seen a…
Read Article

Monitoring irAEs and SAEs in Oncology Immunotherapy Studies

In a previous post, we discussed site selection…
Read Article

Site Selection for Cancer Immunotherapy Studies

Rapid advances in cancer immunotherapy treatments have fueled…
Read Article